CA1162853A - Medicaments contenant des 5-alkyl-pyrimidine nucleosides, et leur emploi comme agents cytostatiques et virostatiques - Google Patents

Medicaments contenant des 5-alkyl-pyrimidine nucleosides, et leur emploi comme agents cytostatiques et virostatiques

Info

Publication number
CA1162853A
CA1162853A CA000373253A CA373253A CA1162853A CA 1162853 A CA1162853 A CA 1162853A CA 000373253 A CA000373253 A CA 000373253A CA 373253 A CA373253 A CA 373253A CA 1162853 A CA1162853 A CA 1162853A
Authority
CA
Canada
Prior art keywords
alkyl
fluorouracil
cytostatic
formula
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000373253A
Other languages
English (en)
Inventor
Kailash K. Gauri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Robugen GmbH Pharmaceutische Fabrik
Original Assignee
Robugen GmbH Pharmaceutische Fabrik
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robugen GmbH Pharmaceutische Fabrik filed Critical Robugen GmbH Pharmaceutische Fabrik
Application granted granted Critical
Publication of CA1162853A publication Critical patent/CA1162853A/fr
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CA000373253A 1980-03-18 1981-03-18 Medicaments contenant des 5-alkyl-pyrimidine nucleosides, et leur emploi comme agents cytostatiques et virostatiques Expired CA1162853A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP3010397.0 1980-03-18
DE19803010397 DE3010397A1 (de) 1980-03-18 1980-03-18 Verwendung von 5-alkyl-pyrimidinnukleosiden als cytostatika

Publications (1)

Publication Number Publication Date
CA1162853A true CA1162853A (fr) 1984-02-28

Family

ID=6097574

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000373253A Expired CA1162853A (fr) 1980-03-18 1981-03-18 Medicaments contenant des 5-alkyl-pyrimidine nucleosides, et leur emploi comme agents cytostatiques et virostatiques

Country Status (4)

Country Link
JP (1) JPS56140921A (fr)
CA (1) CA1162853A (fr)
CH (1) CH655934A5 (fr)
DE (1) DE3010397A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880785A (en) * 1987-08-07 1989-11-14 Mta Kozponti Kemiai Kutato Intezete And Biogal Gyogyszergyar Topical process for treating herpes infections using 5-isopropyl-2'-β-d
US5268365A (en) * 1988-03-11 1993-12-07 Rudolph Frederick B Nucleotides, nucleosides, and nucleobases in immune function restoration enhancement or maintenance

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58152898A (ja) * 1982-03-08 1983-09-10 Taiho Yakuhin Kogyo Kk 2′−デオキシ−5−トリフルオロメチルウリジン誘導体、その製法およびそれを含む抗腫瘍剤
ATA173599A (de) * 1999-10-14 2001-04-15 Lilly Co Eli Pharmazeutisches produkt

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880785A (en) * 1987-08-07 1989-11-14 Mta Kozponti Kemiai Kutato Intezete And Biogal Gyogyszergyar Topical process for treating herpes infections using 5-isopropyl-2'-β-d
AU605875B2 (en) * 1987-08-07 1991-01-24 Biogal Gyogyszergyar Externally applicable, antiviral pharmaceutical composition accumulating in the skin and process for the preparation of same
US5268365A (en) * 1988-03-11 1993-12-07 Rudolph Frederick B Nucleotides, nucleosides, and nucleobases in immune function restoration enhancement or maintenance

Also Published As

Publication number Publication date
JPS56140921A (en) 1981-11-04
DE3010397A1 (de) 1981-10-29
CH655934A5 (en) 1986-05-30

Similar Documents

Publication Publication Date Title
Dyson et al. The synthesis and antiviral activity of some 4'-thio-2'-deoxy nucleoside analogs
US6153594A (en) 5'-O-acylated antiviral nucleosides
DE69634747T2 (de) Aryl-Ester Phosphoramidatderivate von 2',3'-Didehydronukleoside
US6573247B1 (en) Anti-viral pyrimidine nucleoside analogues
EP3486251A1 (fr) Composés chimiques
Mikhailopulo et al. Synthesis and antiviral and cytostatic properties of 3'-deoxy-3'-fluoro-and 2'-azido-3'-fluoro-2', 3'-dideoxy-D-ribofuranosides of natural heterocyclic bases
CS246075B2 (en) Method of 2,2-difluoronucleoside production
WO1993025565A1 (fr) Analogues de nucleosides a base de 1,5-anhydrohexitol et leur utilisation pharmaceutique
KR100272732B1 (ko) 항바이러스성을 나타내는 누클레오시드 및 누클레오시드 유사체의 아실 유도체 및 이 화합물을 함유하는 약학 조성물
US6372725B1 (en) Specific lipid conjugates to nucleoside diphosphates and their use as drugs
CA1162853A (fr) Medicaments contenant des 5-alkyl-pyrimidine nucleosides, et leur emploi comme agents cytostatiques et virostatiques
JP4879398B2 (ja) グリセリルヌクレオチド、それらの製造法および使用
RU2347786C2 (ru) Производные сложноэфирных липидов нуклеотидов
US4730001A (en) Carbocyclic analogues of amino and azido thymidines
Villard et al. An original pronucleotide strategy for the simultaneous delivery of two bioactive drugs
EP2601202B1 (fr) Médicaments en duplex à base de bisphosphonate à ciblage osseux
SANEYOSHI et al. Synthetic nucleosides and nucleotides. XVIII. Synthesis and cytostatic activity of 5-fluoropyrimidine nucleosides of 3-amino-3-deoxy-β-D-ribofuranose and related compounds
Bobek et al. 2'-Fluorinated isonucleosides. 1. Synthesis and biological activity of some methyl 2'-deoxy-2'-fluoro-2'-pyrimidinyl-D-arabinopyranosides
US5574021A (en) Methods of treatment using 2',3'-dideoxy-2',2'-difluoronucleosides
SU961354A1 (ru) 3-Фтор-2,3-дидезоксиаденозин,про вл ющий цитостатическую активность
Jeong et al. Synthesis of a 2, 3-dideoxy-2, 3-difluorofuranose with the D-lyxo configuration. An intramolecular rearrangement of methyl 5-O-benzoyl-2, 3-dideoxy-2, 3-difluoro-D-lyxofuranoside observed during the attempted synthesis of 1-(2, 3-dideoxy-2, 3-difluoro-β-D-lyxofuranosyl) thymine
Smee et al. Synthesis and Anti-Herpetic Activity of A 2′-Fluoroarabinosyl Analog of Trifluridine
Mikhailopulo et al. Synthesis and biological properties of 2-amino-3-fluoro-2, 3-dideoxy-D-pentofuranosides of natural heterocyclic bases
KR100730768B1 (ko) 5'-데옥시-n-알킬옥시카르보닐-5-플루오로사이토신-5'-카르복실산 및 그 유도체와 이들의 제조방법
KR100631754B1 (ko) N-알킬옥시카르보닐-5-플루오로사이토신 유도체 및 그의제조방법

Legal Events

Date Code Title Description
MKEX Expiry